Have your treatment recommendations for urothelial cancer patients changed given the ongoing COVID19 pandemic?  

The therapeutic approach to cancer patients is changing rapidly due to the COVID-19 pandemic. In discussing with colleagues from several different countries, a few themes emerge. Patient visits, surgery, and treatment that is not essential is being deferred. The benefit/risk that we each consider f...

Excellent comments and answer by @Brian I. Rini! Cancer is also a big threat to many patients. It is very hard to make hard & fast decisions in these situations; it is usually a case by case approach, balancing very carefully risks vs benefits, and discussing rationale, data, logistics, details ...